Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:

NCT03875573 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

147

Enrollment

OTHER

Sponsor class

Conditions

Luminal B

Interventions

DRUG: Durvalumab
RADIATION: Stereotactic Body Radiotherapy
DRUG: Oleclumab

Sponsor

Jules Bordet Institute

Collaborators

[object Object]
[object Object]